Time to Move beyond Proving Disparities Exist and Begin Eliminating Them

Thornton discusses the study by Blom et al which examined the differences among 442, 812 patients in receiving lung cancer treatment recommended in the National Comprehensive Cancer Network guidelines between 2,010 and 2,014. Strengths of the study include its large and diverse sample size from a validated database; inclusion of a variety of different lung cancer types, severities, and treatments; and adjustment for patient co-morbidity.